Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
650 |
|
Actual shortage: | 16 (2%) | |
Anticipated shortage: | 3 (0%) | |
Avoided shortage: | 85 (13%) | |
Resolved: | 546 (84%) | |
Discontinuation Reports |
234 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 234 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
83 (9%) |
|
Overdue reports |
1 (5%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CLARUS | 10MG | CAPSULE | Resolved | 2022-06-18 | 2022-09-01 | 163042 |
CLARUS | 40MG | CAPSULE | Resolved | 2022-06-18 | 2022-09-01 | 163045 |
CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2017-11-08 | 2018-05-31 | 28619 |
CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2021-01-05 | 2021-02-03 | 130854 |
ESME 21 | 20MCG 100MCG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51450 |
ESME 28 | 20MCG 100MCG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51453 |
FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2018-12-05 | 2019-03-06 | 68756 |
FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2019-05-22 | 2019-05-29 | 84512 |
FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2019-06-04 | 2019-06-19 | 85557 |
FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2020-01-28 | 2020-05-06 | 104512 |
FREYA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-10-11 | 2022-10-31 | 171506 |
FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2017-11-03 | 2019-03-21 | 28041 |
FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2019-04-03 | 2019-07-03 | 80441 |
FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2020-02-12 | 2020-03-04 | 105774 |
FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2022-10-11 | 2022-10-31 | 171501 |
FULVESTRANT INJECTION | 50MG | SOLUTION | Avoided shortage | 2020-07-02 | 2020-08-17 | 119319 |
FULVESTRANT INJECTION | 50MG | SOLUTION | Avoided shortage | 2020-10-21 | 2020-11-10 | 126796 |
FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2021-01-05 | 2021-12-22 | 130857 |
MYLAN-AMLODIPINE/ATORVASTATIN | 5MG 10MG | TABLET | Resolved | 2017-07-24 | 2017-08-04 | 16832 |
MYLAN-AMLODIPINE/ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2020-01-22 | 2020-04-22 | 103957 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-PRAVASTATIN | 20MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16148 |
MYLAN-PREGABALIN | 25MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51561 |
MYLAN-PREGABALIN | 50MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51567 |
MYLAN-PREGABALIN | 75MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51573 |
MYLAN-PREGABALIN | 150MG | CAPSULE | Discontinued | 2018-06-05 | 2018-08-01 | 51582 |
MYLAN-PREGABALIN | 300MG | CAPSULE | Discontinued | 2018-06-05 | 2018-07-04 | 51588 |
MYLAN-QUETIAPINE | 25MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6778 |
MYLAN-QUETIAPINE | 100MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6781 |
MYLAN-QUETIAPINE | 200MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6784 |
MYLAN-QUETIAPINE | 300MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6788 |
MYLAN-RABEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-17 | 2018-02-15 | 16039 |
MYLAN-RABEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-17 | 2018-02-15 | 16042 |
MYLAN-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6792 |
MYLAN-RAMIPRIL | 2.5MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6797 |
MYLAN-RAMIPRIL | 5.0MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6801 |
MYLAN-RAMIPRIL | 10MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6805 |
MYLAN-RANITIDINE | 150MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6808 |
MYLAN-RANITIDINE | 300MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6811 |
MYLAN-RISEDRONATE | 150MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16049 |
MYLAN-RISEDRONATE | 35MG | TABLET | Discontinued | 2017-07-18 | 2017-11-02 | 16151 |